Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2024 May 21;15:1430750. doi: 10.3389/fimmu.2024.1430750

Retraction: MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3

Frontiers Editorial Office*
PMCID: PMC11148794  PMID: 38835785

Please, find the retraction statement below:

“Following publication, concerns were raised regarding the integrity of the images in the published figures OR regarding the validity of the data presented in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.”.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES